WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Testing Digital Technologies to Help Families Build Healthy Habits
Not Applicable
Completed
- Conditions
- Childhood Obesity
- Interventions
- Behavioral: Virtual Reality Experience
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 54
- Registration Number
- NCT04845568
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Fresh RX: NHS 2020
Not Applicable
Recruiting
- Conditions
- Housing ProblemsPremature BirthHealth Care UtilizationNutrition Deficiency Due to Insufficient FoodPost Partum DepressionFetal ComplicationsBirth WeightFood Deprivation
- Interventions
- Behavioral: FreshRx Nourishing Healthy Starts
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 750
- Registration Number
- NCT04845230
- Locations
- πΊπΈ
Operation Food Search Inc., Saint Louis, Missouri, United States
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
Not Applicable
- Conditions
- Pregnancy RelatedPerinatal Depression
- Interventions
- Behavioral: Individual Prenatal CareBehavioral: EleVATE Group Care
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 390
- Registration Number
- NCT04838210
- Locations
- πΊπΈ
University of Missouri-Kansas City/Truman Health Centers-Kansas City, Kansas City, Missouri, United States
πΊπΈCareSTL Health, Saint Louis, Missouri, United States
πΊπΈFamily Care Health Centers, Saint Louis, Missouri, United States
Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
Phase 2
Active, not recruiting
- Conditions
- Metastatic Head-and-neck Squamous-cell Carcinoma
- Interventions
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 46
- Registration Number
- NCT04831320
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer
Not Applicable
Terminated
- Conditions
- Recurrent Rectal Cancer
- Interventions
- Radiation: Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton TherapyDevice: MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT04827732
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Journey of Life Psychosocial Support Program
Not Applicable
Completed
- Conditions
- PsychologicalChild DevelopmentSocial Values
- Interventions
- Behavioral: Journey of Life
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1395
- Registration Number
- NCT04817098
- Locations
- πΊπ¬
TPO Uganda, Kiryandongo, Uganda
Treatment Uptake Chatbot for Eating Disorders
Not Applicable
Completed
- Conditions
- Eating Disorders
- Interventions
- Behavioral: Motivational InterviewingBehavioral: Motivational Interviewing, Personalized RecommendationBehavioral: PsychoeducationBehavioral: Core Modules OnlyBehavioral: Psychoeducation, Motivational Interviewing, Personalized RecommendationBehavioral: Psychoeducation, Motivational InterviewingBehavioral: Personalized RecommendationBehavioral: Motivational Interviewing, Personalized Recommendation, Repeated AdministrationBehavioral: Personalized Recommendation, Repeated AdministrationBehavioral: Psychoeducation, Repeated AdministrationBehavioral: Psychoeducation, Personalized RecommendationBehavioral: Psychoeducation, Personalized Recommendation, Repeated AdministrationBehavioral: Psychoeducation, Motivational Interviewing, Personalized Recommendation, Repeated AdministrationBehavioral: Repeated AdministrationBehavioral: Psychoeducation, Motivational Interviewing, Repeated AdministrationBehavioral: Motivational Interviewing, Repeated Administration
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 205
- Registration Number
- NCT04806165
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial
Not Applicable
Recruiting
- Conditions
- Asymmetric Hearing LossSingle-sided DeafnessUnilateral Deafness
- Interventions
- Device: Cochlear Implant
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT04793412
- Locations
- πΊπΈ
Washington University School of Medicine/St Louis Children's Hospital, Saint Louis, Missouri, United States
πΊπΈHearts for Hearing, Oklahoma City, Oklahoma, United States
πΊπΈKeck School of Medicine of the University of Southern California, Los Angeles, California, United States
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
Phase 2
Active, not recruiting
- Conditions
- Non Small Cell Lung CancerNon-small Cell Lung CancerNon-small Cell Carcinoma
- Interventions
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT04791839
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Smell in Covid-19 and Efficacy of Nasal Theophylline
Phase 2
Completed
- Conditions
- Covid-19 PandemicSARS-CoV-2 InfectionHyposmiaCovid19AgeusiaHypogeusiaOlfactory DisorderAnosmia
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 51
- Registration Number
- NCT04789499
- Locations
- πΊπΈ
Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States
Β© Copyright 2025. All Rights Reserved by MedPath